Concepts (235)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Rotavirus Vaccines | 57 | 2020 | 203 | 14.41 | Why? |
| Rotavirus Infections | 54 | 2020 | 355 | 11.79 | Why? |
| Rotavirus | 28 | 2020 | 329 | 5.84 | Why? |
| Gastroenteritis | 26 | 2020 | 489 | 4.86 | Why? |
| Intussusception | 9 | 2020 | 102 | 2.90 | Why? |
| Immunization Programs | 23 | 2019 | 2006 | 2.83 | Why? |
| Diarrhea | 22 | 2020 | 2743 | 1.94 | Why? |
| Infant | 54 | 2021 | 30274 | 0.88 | Why? |
| Hospitalization | 33 | 2021 | 54280 | 0.81 | Why? |
| Vaccination | 24 | 2020 | 19050 | 0.79 | Why? |
| Vaccination Coverage | 5 | 2019 | 1249 | 0.66 | Why? |
| Child, Preschool | 45 | 2021 | 36283 | 0.64 | Why? |
| Vaccines, Attenuated | 14 | 2020 | 952 | 0.60 | Why? |
| Immunization Schedule | 8 | 2019 | 1305 | 0.51 | Why? |
| Sentinel Surveillance | 9 | 2019 | 1093 | 0.46 | Why? |
| Camping | 2 | 2021 | 76 | 0.41 | Why? |
| Georgia | 9 | 2022 | 955 | 0.38 | Why? |
| Seizures | 1 | 2018 | 1163 | 0.37 | Why? |
| Feces | 10 | 2019 | 4235 | 0.37 | Why? |
| Population Surveillance | 4 | 2019 | 4967 | 0.36 | Why? |
| Laboratories | 3 | 2021 | 2858 | 0.36 | Why? |
| Acute Disease | 10 | 2018 | 6029 | 0.34 | Why? |
| Wisconsin | 4 | 2021 | 607 | 0.33 | Why? |
| Child Day Care Centers | 2 | 2020 | 208 | 0.33 | Why? |
| Utah | 6 | 2021 | 425 | 0.30 | Why? |
| Zimbabwe | 3 | 2019 | 198 | 0.28 | Why? |
| Infant, Newborn | 17 | 2021 | 23105 | 0.27 | Why? |
| Immunoenzyme Techniques | 4 | 2018 | 448 | 0.26 | Why? |
| Africa South of the Sahara | 2 | 2018 | 1335 | 0.25 | Why? |
| Humans | 100 | 2022 | 930598 | 0.25 | Why? |
| Genotype | 4 | 2018 | 4697 | 0.25 | Why? |
| World Health Organization | 5 | 2018 | 4213 | 0.25 | Why? |
| Kenya | 3 | 2020 | 887 | 0.23 | Why? |
| Child | 29 | 2021 | 70012 | 0.23 | Why? |
| Student Health Services | 1 | 2021 | 69 | 0.21 | Why? |
| Diphtheria-Tetanus-Pertussis Vaccine | 2 | 2019 | 92 | 0.21 | Why? |
| Age Distribution | 3 | 2019 | 3567 | 0.21 | Why? |
| Environmental Exposure | 2 | 2020 | 1558 | 0.20 | Why? |
| Cost-Benefit Analysis | 3 | 2018 | 2259 | 0.19 | Why? |
| Philippines | 2 | 2018 | 568 | 0.19 | Why? |
| Infant, Very Low Birth Weight | 1 | 2018 | 62 | 0.18 | Why? |
| Outpatients | 3 | 2021 | 3417 | 0.18 | Why? |
| Africa, Southern | 1 | 2017 | 78 | 0.18 | Why? |
| Africa, Eastern | 1 | 2017 | 90 | 0.18 | Why? |
| Rwanda | 1 | 2018 | 270 | 0.17 | Why? |
| Disease Outbreaks | 6 | 2021 | 27595 | 0.17 | Why? |
| Mozambique | 1 | 2017 | 205 | 0.17 | Why? |
| International Classification of Diseases | 1 | 2020 | 265 | 0.17 | Why? |
| Caribbean Region | 1 | 2018 | 349 | 0.17 | Why? |
| Seasons | 6 | 2019 | 4071 | 0.17 | Why? |
| Dose-Response Relationship, Immunologic | 1 | 2018 | 593 | 0.16 | Why? |
| Vaccine Potency | 1 | 2018 | 339 | 0.16 | Why? |
| School Health Services | 1 | 2021 | 294 | 0.16 | Why? |
| School Teachers | 1 | 2021 | 345 | 0.16 | Why? |
| Nucleocapsid | 1 | 2021 | 734 | 0.16 | Why? |
| United States | 14 | 2021 | 46150 | 0.16 | Why? |
| Infant Mortality | 1 | 2018 | 268 | 0.15 | Why? |
| Male | 41 | 2022 | 367725 | 0.15 | Why? |
| Reassortant Viruses | 1 | 2018 | 287 | 0.15 | Why? |
| Africa | 3 | 2019 | 2986 | 0.14 | Why? |
| Ghana | 1 | 2018 | 763 | 0.14 | Why? |
| Adolescent | 20 | 2022 | 86841 | 0.14 | Why? |
| Female | 39 | 2022 | 380317 | 0.14 | Why? |
| Assisted Living Facilities | 1 | 2018 | 264 | 0.14 | Why? |
| Virus Shedding | 2 | 2021 | 5834 | 0.14 | Why? |
| Incidence | 6 | 2021 | 25622 | 0.13 | Why? |
| Prisons | 2 | 2021 | 980 | 0.13 | Why? |
| Adverse Drug Reaction Reporting Systems | 1 | 2018 | 694 | 0.13 | Why? |
| Sensitivity and Specificity | 7 | 2021 | 22971 | 0.13 | Why? |
| Epidemiological Monitoring | 4 | 2018 | 3493 | 0.13 | Why? |
| Schools | 4 | 2022 | 4187 | 0.13 | Why? |
| Antigens, Viral | 5 | 2021 | 6298 | 0.12 | Why? |
| Ageusia | 1 | 2021 | 918 | 0.12 | Why? |
| Latin America | 1 | 2018 | 1721 | 0.12 | Why? |
| Glycated Hemoglobin A | 1 | 2021 | 1316 | 0.12 | Why? |
| Disease Transmission, Infectious | 3 | 2021 | 9044 | 0.12 | Why? |
| Community Health Services | 1 | 2021 | 1000 | 0.11 | Why? |
| Prisoners | 1 | 2020 | 738 | 0.11 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.11 | Why? |
| Contact Tracing | 8 | 2022 | 8448 | 0.11 | Why? |
| Adult | 26 | 2022 | 244371 | 0.11 | Why? |
| Program Evaluation | 1 | 2019 | 1929 | 0.11 | Why? |
| Odds Ratio | 2 | 2019 | 5861 | 0.10 | Why? |
| Young Adult | 17 | 2022 | 93724 | 0.10 | Why? |
| Case-Control Studies | 5 | 2019 | 17671 | 0.10 | Why? |
| Zinc | 1 | 2017 | 817 | 0.10 | Why? |
| Safety Management | 1 | 2018 | 1093 | 0.10 | Why? |
| Homeless Persons | 1 | 2021 | 1171 | 0.10 | Why? |
| Family | 2 | 2021 | 2909 | 0.10 | Why? |
| Louisiana | 2 | 2021 | 353 | 0.10 | Why? |
| Health Facilities | 1 | 2018 | 1230 | 0.10 | Why? |
| Symptom Assessment | 2 | 2021 | 4967 | 0.10 | Why? |
| Probiotics | 1 | 2017 | 694 | 0.10 | Why? |
| Residence Characteristics | 1 | 2020 | 1927 | 0.10 | Why? |
| Public Health Surveillance | 2 | 2020 | 3129 | 0.10 | Why? |
| Patient Care Management | 1 | 2021 | 1514 | 0.10 | Why? |
| Antibodies, Viral | 6 | 2022 | 51949 | 0.10 | Why? |
| Risk | 2 | 2020 | 5288 | 0.10 | Why? |
| Colorado | 2 | 2021 | 434 | 0.10 | Why? |
| Nucleocapsid Proteins | 1 | 2021 | 3120 | 0.09 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.09 | Why? |
| Inpatients | 2 | 2021 | 5161 | 0.09 | Why? |
| Middle Aged | 21 | 2022 | 270681 | 0.09 | Why? |
| Malawi | 2 | 2018 | 287 | 0.09 | Why? |
| Emergency Service, Hospital | 4 | 2019 | 14232 | 0.08 | Why? |
| Autopsy | 1 | 2019 | 3495 | 0.08 | Why? |
| Genetic Variation | 2 | 2018 | 3919 | 0.08 | Why? |
| Family Characteristics | 3 | 2021 | 2551 | 0.08 | Why? |
| Internationality | 1 | 2019 | 3297 | 0.08 | Why? |
| Age Factors | 4 | 2021 | 21039 | 0.08 | Why? |
| Polymerase Chain Reaction | 1 | 2021 | 6740 | 0.08 | Why? |
| Students | 2 | 2022 | 5255 | 0.08 | Why? |
| Rural Population | 1 | 2018 | 2408 | 0.08 | Why? |
| Immunoglobulin A | 1 | 2017 | 3567 | 0.07 | Why? |
| Clinical Laboratory Techniques | 3 | 2020 | 23402 | 0.07 | Why? |
| Registries | 3 | 2019 | 12327 | 0.07 | Why? |
| RNA, Viral | 5 | 2021 | 32276 | 0.06 | Why? |
| Olfaction Disorders | 1 | 2021 | 3704 | 0.06 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.06 | Why? |
| Time-to-Treatment | 1 | 2018 | 5883 | 0.05 | Why? |
| Survival Analysis | 3 | 2019 | 7592 | 0.05 | Why? |
| Aged | 13 | 2021 | 215776 | 0.05 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.05 | Why? |
| Ambulatory Care | 1 | 2017 | 4947 | 0.05 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.05 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.05 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.05 | Why? |
| Mauritania | 1 | 2019 | 39 | 0.05 | Why? |
| Internet | 1 | 2018 | 6204 | 0.05 | Why? |
| Arizona | 1 | 2021 | 416 | 0.05 | Why? |
| Fever | 3 | 2021 | 7795 | 0.05 | Why? |
| DNA Viruses | 1 | 2021 | 184 | 0.05 | Why? |
| Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 7868 | 0.05 | Why? |
| Illinois | 1 | 2021 | 468 | 0.05 | Why? |
| Direct Service Costs | 1 | 2018 | 9 | 0.05 | Why? |
| Minnesota | 1 | 2021 | 509 | 0.05 | Why? |
| Hypertension | 1 | 2021 | 8895 | 0.05 | Why? |
| Specimen Handling | 3 | 2021 | 6190 | 0.05 | Why? |
| Capital Financing | 1 | 2018 | 35 | 0.05 | Why? |
| Togo | 1 | 2018 | 95 | 0.05 | Why? |
| Diabetes Mellitus | 1 | 2021 | 8207 | 0.05 | Why? |
| Genetic Drift | 1 | 2018 | 54 | 0.05 | Why? |
| Botswana | 1 | 2018 | 98 | 0.05 | Why? |
| Prospective Studies | 5 | 2021 | 43301 | 0.04 | Why? |
| Asymptomatic Diseases | 2 | 2021 | 3444 | 0.04 | Why? |
| Chicago | 1 | 2021 | 653 | 0.04 | Why? |
| Bolivia | 1 | 2018 | 187 | 0.04 | Why? |
| Aged, 80 and over | 7 | 2021 | 88759 | 0.04 | Why? |
| Reverse Transcription | 1 | 2021 | 673 | 0.04 | Why? |
| Cities | 2 | 2020 | 4937 | 0.04 | Why? |
| Lactobacillus rhamnosus | 1 | 2017 | 23 | 0.04 | Why? |
| Risk Assessment | 3 | 2021 | 25439 | 0.04 | Why? |
| Coinfection | 1 | 2018 | 6820 | 0.04 | Why? |
| Child Mortality | 1 | 2019 | 163 | 0.04 | Why? |
| Treatment Outcome | 3 | 2019 | 51732 | 0.04 | Why? |
| Zambia | 1 | 2018 | 401 | 0.04 | Why? |
| Burkina Faso | 1 | 2017 | 302 | 0.04 | Why? |
| Senegal | 1 | 2017 | 283 | 0.04 | Why? |
| Dyspnea | 2 | 2021 | 3847 | 0.04 | Why? |
| Medically Uninsured | 1 | 2019 | 237 | 0.04 | Why? |
| Geography, Medical | 1 | 2019 | 537 | 0.04 | Why? |
| Cough | 2 | 2021 | 4891 | 0.04 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2022 | 13720 | 0.04 | Why? |
| Universities | 2 | 2021 | 4374 | 0.04 | Why? |
| Taste | 1 | 2021 | 715 | 0.04 | Why? |
| Genome, Viral | 1 | 2018 | 13157 | 0.04 | Why? |
| Multimorbidity | 1 | 2021 | 703 | 0.04 | Why? |
| Retrospective Studies | 7 | 2021 | 105322 | 0.04 | Why? |
| Cohort Studies | 4 | 2021 | 36005 | 0.04 | Why? |
| Hospital Costs | 1 | 2018 | 274 | 0.04 | Why? |
| Prevalence | 2 | 2017 | 25773 | 0.04 | Why? |
| Fomites | 1 | 2021 | 709 | 0.04 | Why? |
| Myalgia | 1 | 2021 | 1015 | 0.04 | Why? |
| Surveys and Questionnaires | 2 | 2021 | 43792 | 0.04 | Why? |
| Logistic Models | 2 | 2021 | 9089 | 0.04 | Why? |
| Nose | 1 | 2021 | 1093 | 0.03 | Why? |
| Placebos | 1 | 2017 | 629 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.03 | Why? |
| RNA | 1 | 2021 | 1278 | 0.03 | Why? |
| Databases, Factual | 2 | 2019 | 6248 | 0.03 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.03 | Why? |
| Clinical Laboratory Services | 1 | 2020 | 781 | 0.03 | Why? |
| Haemophilus Vaccines | 1 | 2013 | 76 | 0.03 | Why? |
| Cluster Analysis | 1 | 2021 | 3001 | 0.03 | Why? |
| Haemophilus influenzae | 1 | 2013 | 196 | 0.03 | Why? |
| Developing Countries | 2 | 2018 | 4283 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2021 | 17020 | 0.03 | Why? |
| Nasopharynx | 2 | 2021 | 10224 | 0.03 | Why? |
| Socioeconomic Factors | 2 | 2021 | 8495 | 0.03 | Why? |
| Disease Progression | 2 | 2021 | 13580 | 0.03 | Why? |
| Asia | 1 | 2018 | 2399 | 0.03 | Why? |
| Smell | 1 | 2021 | 1851 | 0.03 | Why? |
| Information Seeking Behavior | 1 | 2018 | 539 | 0.03 | Why? |
| Morbidity | 1 | 2017 | 1426 | 0.03 | Why? |
| California | 1 | 2018 | 2047 | 0.03 | Why? |
| Bangladesh | 1 | 2017 | 1620 | 0.03 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.03 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.03 | Why? |
| India | 2 | 2018 | 11875 | 0.03 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.03 | Why? |
| Hospitals, Teaching | 1 | 2018 | 1609 | 0.02 | Why? |
| South Africa | 1 | 2020 | 3326 | 0.02 | Why? |
| Fatigue | 1 | 2021 | 2479 | 0.02 | Why? |
| Workflow | 1 | 2019 | 2373 | 0.02 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 1261 | 0.02 | Why? |
| Mexico | 1 | 2018 | 2787 | 0.02 | Why? |
| Cost of Illness | 1 | 2020 | 1903 | 0.02 | Why? |
| Taiwan | 1 | 2017 | 2556 | 0.02 | Why? |
| Income | 1 | 2018 | 1564 | 0.02 | Why? |
| Masks | 2 | 2021 | 8528 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2020 | 6543 | 0.02 | Why? |
| Premature Birth | 1 | 2019 | 2151 | 0.02 | Why? |
| Hospitals, Pediatric | 1 | 2017 | 1792 | 0.02 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3633 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Hospitals, University | 1 | 2018 | 4173 | 0.02 | Why? |
| Global Health | 2 | 2019 | 13911 | 0.02 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.02 | Why? |
| Decision Making | 1 | 2018 | 3132 | 0.02 | Why? |
| Membrane Glycoproteins | 1 | 2013 | 2273 | 0.02 | Why? |
| Emergency Medical Services | 1 | 2019 | 3557 | 0.02 | Why? |
| Patient Acceptance of Health Care | 1 | 2021 | 5002 | 0.01 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.01 | Why? |
| Virus Replication | 1 | 2021 | 14331 | 0.01 | Why? |
| Social Isolation | 1 | 2020 | 5932 | 0.01 | Why? |
| Phylogeny | 1 | 2018 | 13341 | 0.01 | Why? |
| United Kingdom | 1 | 2018 | 18046 | 0.01 | Why? |
| Brazil | 1 | 2013 | 12582 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.01 | Why? |